He has a demonstrated history of taking early-stage companies from no commercial experience to over $100M+ in annual sales, with a strong competence in complex problem solving and commercial execution. Rob has expansive skill sets that extend to Global Sales and Marketing, Sales Operations, Customer Service and Market Access/Reimbursement, with specific proficiency in building and leading high-performance teams which have been recognized for excellence throughout the MedTech industry. He is a proud graduate of The University of North Carolina at Chapel Hill. Rob has recently onboarded at Organon, a women’s health spinoff of Merck, and is heading up the transition as Alydia Health (where he was the CEO), a medical device startup focused on postpartum hemorrhage, was recently acquired by the company.